# Blade Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/blade-therapeutics

- Industry: Biotechnology
- Headquarters: South San Francisco, US
- Website: www.blademed.com
- Total disclosed funding: $34M
- Latest round: Series B (Jun 8, 2016)
- Investors on record: 6

## About

Founded in 2015 and based in California, US, Blade Therapeutics, Inc. researches and develops novel therapies for fibrotic diseases in the liver, lung, kidney, and skin caused by increased levels of autotaxin/lysophosphatidic acid (LPA).

## Funding rounds

- Series B, Jun 8, 2016, $27M — OUP (Osage University Partners), MPM BioImpact, Bristol-Myers Squibb Company, Pfizer Venture Investments, Deerfield Management, Novartis
- Series A, Jul 6, 2015, $6.5M — MPM BioImpact
- Seed, May 4, 2015 — MPM BioImpact

## Investors

- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Seed, Series A, Series B
- OUP (Osage University Partners) (https://capitalatlas.ai/funds/oup-osage-university-partners) — Series B
- Bristol-Myers Squibb Company — Series B
- Pfizer Venture Investments (https://capitalatlas.ai/funds/pfizer-venture-investments) — Series B
- Deerfield Management (https://capitalatlas.ai/funds/deerfield-management) — Series B
- Novartis — Series B